Literature DB >> 36182953

Understanding multimorbidity trajectories in Scotland using sequence analysis.

G Cezard1,2, F Sullivan3, K Keenan4.   

Abstract

Understanding how multiple conditions develop over time is of growing interest, but there is currently limited methodological development on the topic, especially in understanding how multimorbidity (the co-existence of at least two chronic conditions) develops longitudinally and in which order diseases occur. We aim to describe how a longitudinal method, sequence analysis, can be used to understand the sequencing of common chronic diseases that lead to multimorbidity and the socio-demographic factors and health outcomes associated with typical disease trajectories. We use the Scottish Longitudinal Study (SLS) linking the Scottish census 2001 to disease registries, hospitalisation and mortality records. SLS participants aged 40-74 years at baseline were followed over a 10-year period (2001-2011) for the onset of three commonly occurring diseases: diabetes, cardiovascular disease (CVD), and cancer. We focused on participants who transitioned to at least two of these conditions over the follow-up period (N = 6300). We use sequence analysis with optimal matching and hierarchical cluster analysis to understand the process of disease sequencing and to distinguish typical multimorbidity trajectories. Socio-demographic differences between specific disease trajectories were evaluated using multinomial logistic regression. Poisson and Cox regressions were used to assess differences in hospitalisation and mortality outcomes between typical trajectories. Individuals who transitioned to multimorbidity over 10 years were more likely to be older and living in more deprived areas than the rest of the population. We found seven typical trajectories: later fast transition to multimorbidity, CVD start with slow transition to multimorbidity, cancer start with slow transition to multimorbidity, diabetes start with slow transition to multimorbidity, fast transition to both diabetes and CVD, fast transition to multimorbidity and death, fast transition to both cancer and CVD. Those who quickly transitioned to multimorbidity and death were the most vulnerable, typically older, less educated, and more likely to live in more deprived areas. They also experienced higher number of hospitalisations and overnight stays while still alive. Sequence analysis can strengthen our understanding of typical disease trajectories when considering a few key diseases. This may have implications for more active clinical review of patients beginning quick transition trajectories.
© 2022. The Author(s).

Entities:  

Mesh:

Year:  2022        PMID: 36182953      PMCID: PMC9526700          DOI: 10.1038/s41598-022-20546-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  23 in total

1.  Trajectories of multimorbidity and impacts on successful aging.

Authors:  Hui-Chuan Hsu
Journal:  Exp Gerontol       Date:  2015-04-12       Impact factor: 4.032

2.  Multimorbidity in primary care: developing the research agenda.

Authors:  Stewart W Mercer; Susan M Smith; Sally Wyke; Tom O'Dowd; Graham C M Watt
Journal:  Fam Pract       Date:  2009-04       Impact factor: 2.267

Review 3.  Evidence on multimorbidity from definition to intervention: An overview of systematic reviews.

Authors:  Xiaolin Xu; Gita D Mishra; Mark Jones
Journal:  Ageing Res Rev       Date:  2017-05-13       Impact factor: 10.895

Review 4.  A Systematic Review of Cost-of-Illness Studies of Multimorbidity.

Authors:  Lili Wang; Lei Si; Fiona Cocker; Andrew J Palmer; Kristy Sanderson
Journal:  Appl Health Econ Health Policy       Date:  2018-02       Impact factor: 2.561

5.  A retrospective cohort study of comorbidity trajectories associated with traumatic brain injury in veterans of the Iraq and Afghanistan wars.

Authors:  Mary Jo Pugh; Erin P Finley; Chen-Pin Wang; Laurel A Copeland; Carlos A Jaramillo; Alicia A Swan; Christine A Elnitsky; Luci K Leykum; Eric M Mortensen; Blessen A Eapen; Polly H Noel; Jacqueline A Pugh
Journal:  Brain Inj       Date:  2016       Impact factor: 2.311

Review 6.  Aging with multimorbidity: a systematic review of the literature.

Authors:  Alessandra Marengoni; Sara Angleman; René Melis; Francesca Mangialasche; Anita Karp; Annika Garmen; Bettina Meinow; Laura Fratiglioni
Journal:  Ageing Res Rev       Date:  2011-03-23       Impact factor: 10.895

7.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.

Authors:  Karen Barnett; Stewart W Mercer; Michael Norbury; Graham Watt; Sally Wyke; Bruce Guthrie
Journal:  Lancet       Date:  2012-05-10       Impact factor: 79.321

8.  Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients.

Authors:  Anders Boeck Jensen; Pope L Moseley; Tudor I Oprea; Sabrina Gade Ellesøe; Robert Eriksson; Henriette Schmock; Peter Bjødstrup Jensen; Lars Juhl Jensen; Søren Brunak
Journal:  Nat Commun       Date:  2014-06-24       Impact factor: 14.919

9.  Rising to the challenge of multimorbidity.

Authors:  Christopher J M Whitty; Carrie MacEwen; Andrew Goddard; Derek Alderson; Martin Marshall; Catherine Calderwood; Frank Atherton; Michael McBride; John Atherton; Helen Stokes-Lampard; Wendy Reid; Stephen Powis; Clare Marx
Journal:  BMJ       Date:  2020-01-06

10.  Multimorbidity: the case for prevention.

Authors:  Anna Head; Kate Fleming; Chris Kypridemos; Jonathan Pearson-Stuttard; Martin O'Flaherty
Journal:  J Epidemiol Community Health       Date:  2020-10-05       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.